Department of Health and Social Care
NHS to partner with Commonwealth nations to stop superbugs
Volunteer NHS clinical staff will work alongside local health workers in Ghana, Tanzania, Uganda and Zambia to tackle antimicrobial resistance (AMR).
The new Commonwealth Partnerships for Antimicrobial Stewardship (AMS) scheme is funded by the UK Department of Health and Social Care’s Fleming Fund.
The scheme will send up to 12 volunteer NHS pharmacists and specialist nurses to Ghana, Tanzania, Uganda and Zambia to work with local health workers against AMR.
It will see NHS and national teams work together to help to keep antibiotics working better for longer and stop the emergence of superbugs. They will do this by:
- improving the detection and monitoring of resistant infections at hospital level
- taking measures to reduce infection
- putting steps in place to use antibiotics effectively
It will be delivered in collaboration with the Commonwealth Pharmacists Association (CPA) and the Tropical Health Education Trust (THET), an international NGO with expertise in delivering global health partnerships.
AMR occurs when micro-organisms survive exposure to a medicine that would normally kill them, such as antibiotics, antimalarials and antivirals. These micro-organisms are often referred to as ‘superbugs’.
The independent review on antimicrobial resistance estimated that at least 700,000 deaths globally each year are from drug-resistant infections such as bacterial infections, malaria and HIV/AIDS.
The review also estimated that deaths from AMR could increase to 10 million each year by 2050 and cost the global economy up to $100 trillion US dollars.
It is thought that 5,000 deaths are already caused every year in the UK alone by antibiotics no longer working for some infections. If we do not find a solution, everyday procedures such as caesarean sections, cancer therapy, and hip replacements will become extremely dangerous.
Chief Medical Officer for England, Professor Dame Sally Davies, said:
I am delighted that UK aid – provided through the government’s Fleming Fund – will enable these vital partnerships between our fantastic NHS staff and their counterparts overseas to take place.
AMR poses a risk to us all, wherever we call home – collaboration of this kind with our friends and neighbours internationally will be all the more important if we are to tackle this challenge together.
This scheme will play a crucial role in allowing specialists to share expertise and strengthen approaches to antimicrobial stewardship in hospitals both at home and abroad.
Latest News from
Department of Health and Social Care
Cold weather health warnings issued by PHE13/12/2018 14:20:00
Cold weather puts young children, people over 65 and those with heart and lung conditions at risk from low temperatures.
Preventable illness is factor in slower life expectancy increases13/12/2018 10:10:10
A new report from Public Health England shows that preventable illness is one of many factors behind slowdown in raising life expectancy.
Health and Social Care Secretary bans fax machines in NHS11/12/2018 10:10:10
Matt Hancock has banned the NHS from buying fax machines and has ordered a complete phase-out by April 2020.
Matt Hancock orders review into overprescribing in the NHS10/12/2018 15:10:00
The review will focus on patients who take multiple medicines, to ensure patients are receiving the most appropriate treatment for their needs.
100,000 whole genomes sequenced in the NHS07/12/2018 13:10:00
The 100,000 Genomes Project has sequenced 100,000 whole genomes, helping to improve diagnosis and treatment for patients with rare diseases and cancer.
£1 billion of funding to upgrade NHS services in England07/12/2018 10:10:10
A total of 75 projects will receive money to upgrade facilities and treat more patients, including mental health and new integrated care services in the community.
Government commits to reform the Mental Health Act07/12/2018 10:10:10
The government has announced new legislation to reform mental health care.
NHS to save £1 billion on its medicines bill in 201906/12/2018 14:25:00
A new 5-year deal has been finalised with the pharmaceutical industry to give patients faster access to new medicines.